Concepedia

Publication | Open Access

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

DOIFull Paper Access

228

Citations

45

References

2009

Year

Takashi Shimada, Itaru Urakawa, Tamara Isakova, Y. Yamazaki, Michael F. Epstein, Katherine Wesseling‐Perry, Myles Wolf, Isidro B. Salusky, Harald Jüppner
The Journal of Clinical Endocrinology & Metabolism

Abstract

Our results provide strong evidence for the conclusion that virtually all circulating FGF23 in dialysis patients is intact and biologically active.

References

YearCitations

Page 1